tiprankstipranks
Advertisement
Advertisement

HALO Stock Latest News

Halozyme Earnings Call Highlights Royalty-Fueled Growth
Company AnnouncementsHalozyme Earnings Call Highlights Royalty-Fueled Growth
18d ago
HALO
Halozyme price target lowered to $93 from $96 at Morgan Stanley
PremiumThe Fly
Halozyme price target lowered to $93 from $96 at Morgan Stanley
19d ago
HALO
Halozyme Maintained at Buy as Strong Execution and Shareholder Returns Offset Modest Price Target Trim to $93
PremiumRatings
Halozyme Maintained at Buy as Strong Execution and Shareholder Returns Offset Modest Price Target Trim to $93
19d ago
HALO
Analyst Reiterates Buy on Halozyme, Citing Underappreciated Growth and Maintaining $96 Price Target
PremiumRatings
Analyst Reiterates Buy on Halozyme, Citing Underappreciated Growth and Maintaining $96 Price Target
19d ago
HALO
Halozyme reports Q1 non-GAAP EPS $1.60, consensus $1.52
PremiumThe Fly
Halozyme reports Q1 non-GAAP EPS $1.60, consensus $1.52
19d ago
HALO
Halozyme still sees 2026 non-GAAP EPS $7.75 to $8.25, consensus $8.09
PremiumThe FlyHalozyme still sees 2026 non-GAAP EPS $7.75 to $8.25, consensus $8.09
19d ago
HALO
HALO Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
HALO Earnings this Week: How Will it Perform?
22d ago
HALO
Halozyme Stockholders Back Board, Pay and Auditor Choices
Premium
Company Announcements
Halozyme Stockholders Back Board, Pay and Auditor Choices
23d ago
8K
HALO
Halozyme announces global collaboration and license agreement with GSK
PremiumThe Fly
Halozyme announces global collaboration and license agreement with GSK
23d ago
GSK
HALO
Halozyme licenses Hypercon technology to Oruka Therapeutics in psoriasis
PremiumThe Fly
Halozyme licenses Hypercon technology to Oruka Therapeutics in psoriasis
24d ago
HALO
ORKA
Halozyme names Darren Snellgrove as CFO
PremiumThe Fly
Halozyme names Darren Snellgrove as CFO
1M ago
JNJ
HALO
Halozyme Appoints New Chief Financial Officer to Drive Growth
PremiumCompany Announcements
Halozyme Appoints New Chief Financial Officer to Drive Growth
1M ago
8K
HALO
Halozyme price target raised to $95 from $90 at H.C. Wainwright
PremiumThe FlyHalozyme price target raised to $95 from $90 at H.C. Wainwright
1M ago
HALO
Halozyme price target raised to $96 from $94 at Morgan Stanley
Premium
The Fly
Halozyme price target raised to $96 from $94 at Morgan Stanley
1M ago
HALO
Halozyme: Underappreciated, Durable Royalty-Driven Growth Beyond 2028 Supports Buy Rating
Premium
Ratings
Halozyme: Underappreciated, Durable Royalty-Driven Growth Beyond 2028 Supports Buy Rating
2M ago
HALO
Halozyme enters global global collaboration and license agreement with Vertex
PremiumThe Fly
Halozyme enters global global collaboration and license agreement with Vertex
2M ago
HALO
VRTX
Halozyme Names David Ramsay Interim Chief Financial Officer
PremiumCompany Announcements
Halozyme Names David Ramsay Interim Chief Financial Officer
3M ago
8K
HALO
Halozyme names David Ramsay as Interim CFO
PremiumThe Fly
Halozyme names David Ramsay as Interim CFO
3M ago
HALO
Halozyme price target raised to $94 from $78 at Morgan Stanley
PremiumThe Fly
Halozyme price target raised to $94 from $78 at Morgan Stanley
3M ago
HALO
Halozyme price target raised to $90 from $75 at Benchmark
PremiumThe FlyHalozyme price target raised to $90 from $75 at Benchmark
3M ago
HALO
Halozyme price target raised to $75 from $65 at Wells Fargo
Premium
The Fly
Halozyme price target raised to $75 from $65 at Wells Fargo
3M ago
HALO
Halozyme Earnings Call Highlights Royalty-Fueled Growth
Premium
Company Announcements
Halozyme Earnings Call Highlights Royalty-Fueled Growth
3M ago
HALO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >